Longitudinal Cognitive Assessment by Bo… | Clinical Trial

Key information

Conditions

Alzheimer Disease Arterial Occlusive Diseases Arteriosclerosis Autoimmune Diseases Autoimmune Diseases of the Nervous System Basal Ganglia Diseases Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Cognition Disorders Cognitive Dysfunction Dementia Dementia, Vascular Demyelinating Autoimmune Diseases, CNS Demyelinating Diseases Frontotemporal Dementia Frontotemporal Lobar Degeneration Immune System Diseases Intracranial Arterial Diseases Intracranial Arteriosclerosis Leukoencephalopathies Mental Disorders Metabolic Diseases Mild Cognitive Impairment Movement Disorders Multiple Sclerosis Nervous System Diseases Neurocognitive Disorders Neurodegenerative Diseases Nutritional and Metabolic Diseases Parkinson Disease Parkinsonian Disorders Proteostasis Deficiencies Synucleinopathies TBI TDP-43 Proteinopathies Tauopathies Vascular Dementia Vascular Diseases

Age range

50 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

Andrey Vyshedskiy

Miami, Florida, 33156, United States

Location status: Recruiting

Location contact

Andrey Vyshedskiy

CONTACT

[email protected]

617-433-8577

About this study

The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not- repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.

BoCA includes eight subtests in the following domains: Memory/Immediate Recall, Memory/Delayed Recall, Executive function/ Visuospatial, Executive function/ Mental rotation, Attention, Mental math, Language/Prefrontal Synthesis, and Orientation. The maximum total score is 30. Higher score indicates better cognitive performance.

After BoCA is completed, the domain scores and total score are provided immediately. Users will also receive an email with the link to the full report with progress charts.

The BoCA evaluation can help doctors figure out if an underlying condition is causing a patient's cognitive decline. Many treatable conditions such as sleep disorders, mood problems, heavy metal accumulation, as well as lack of movement and social interactions can affect memory and thinking.

Our goal is to reduce barriers for patients to receive the testing that may benefit their treatment and health through the use of digital technology.

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

age 50 or older

Exclusion criteria

younger than 50 years

Treatment and study plan

Boston Cognitive Assessment (BoCA)

Diagnostic Test

The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.

BoCA includes eight subtests in the following domains: Memory/Immediate Recall, Memory/Delayed Recall, Executive function/ Visuospatial, Executive function/ Mental rotation, Attention, Mental math, Language/Prefrontal Synthesis, and Orientation. The maximum total score is 30. Higher score indicates better cognitive performance.

After BoCA is completed, the domain scores and total score are provided immediately. Users will also receive an email with the link to the full report with progress charts.

Primary outcomes

Boston Cognitive Assessment (BoCA)

Time frame: through study completion, an average of 1 year

The Boston Cognitive Assessment (BoCA) is a self-administered online test intended for longitudinal cognitive monitoring. BoCA uses random not-repeating tasks to minimize learning effects. BoCA was developed to evaluate the effects of treatment in longitudinal clinical trials and available gratis to individuals and professionals.

Study contacts

Contact information is provided by the study sponsor or research team.

ANDREY VYSHEDSKIY, Ph.D.

CONTACT

[email protected]

6174338577

Sponsors and collaborators

Lead sponsor

Alzheimer's Light LLC

Industry

Registry information

Acronym: BoCA

Important dates

Study start: 2019
Primary completion: 2029
Study completion: 2029
First posted: Oct 3, 2019
Registry last updated: Aug 1, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Recruiting